Literature DB >> 9170764

The influence of psychological distress on use of genetic testing for cancer risk.

C Lerman1, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch.   

Abstract

The recent identification of BRCA1, a breast cancer susceptibility gene, offers an unprecedented opportunity for high-risk individuals to learn whether they are genetically predisposed to develop breast or ovarian cancer. This study examined the relationships between psychological distress and use of BRCA1 testing by 149 high-risk individuals from hereditary cancer families. After a baseline assessment of demographics, objective risk, cancer-specific distress, and global distress (depressive symptoms), study participants were offered the opportunity to receive genetic counseling and to learn whether they carry a mutation in the BRCA1 gene. Overall, 58% of study participants requested BRCA1 test results, and 42% declined to learn their genetic status. After controlling for demographic factors and risk status, cancer-specific distress was significantly and positively related to BRCA1 test use, whereas global distress was unrelated to test use.

Entities:  

Mesh:

Year:  1997        PMID: 9170764     DOI: 10.1037//0022-006x.65.3.414

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  36 in total

1.  Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.

Authors:  L N Lodder; P G Frets; R W Trijsburg; E J Meijers-Heijboer; J G Klijn; H J Duivenvoorden; A Tibben; A Wagner; C A van der Meer; P Devilee; C J Cornelisse; M F Niermeijer
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

2.  Heightened psychobiological reactivity to laboratory stressors in healthy women at familial risk for breast cancer.

Authors:  Heiddis B Valdimarsdottir; Sandra G Zakowski; William Gerin; Jean Mamakos; Thomas Pickering; Dana H Bovbjerg
Journal:  J Behav Med       Date:  2002-02

3.  The role of distress in uptake and response to predisposition genetic testing: the BMPR2 experience.

Authors:  Diana L Jones; Ellen W Clayton
Journal:  Genet Test Mol Biomarkers       Date:  2011-11-15

4.  Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options.

Authors:  Jacqueline Duffour; Audrey Combes; Evelyne Crapez; Florence Boissière-Michot; Frédéric Bibeau; Pierre Senesse; Marc Ychou; Julie Courraud; Hélène de Forges; Lise Roca
Journal:  J Genet Couns       Date:  2015-09-22       Impact factor: 2.537

5.  Family environments of women seeking BRCA1/BRCA2 genetic mutation testing: an exploratory analysis.

Authors:  Lisa A Keenan; Karen T Lesniak; Charles A Guarnaccia; Becky Althaus; Gaby Ethington; Joanne L Blum
Journal:  J Genet Couns       Date:  2004-04       Impact factor: 2.537

6.  Factors associated with an individuals' decision to withdraw from genetic counseling for BRCA1 and BRCA2 genes mutations: are personality traits involved?

Authors:  Anita Caruso; Cristina Vigna; Valentina Bigazzi; Carlo Leone; Gabriella Maggi; Aline Martayan; Fabio M Sega; Francesco Cognetti; Antonella Savarese
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

7.  Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors.

Authors:  Maija Reblin; Monica L Kasting; Kelli Nam; Courtney L Scherr; Jongphil Kim; Ram Thapa; Cathy D Meade; M Catherine Lee; Tuya Pal; Gwendolyn P Quinn; Susan T Vadaparampil
Journal:  Breast J       Date:  2018-11-28       Impact factor: 2.431

8.  Withdrawal from genetic counselling for cancer.

Authors:  Eveline Bleiker; Gea Wigbout; Anja van Rens; Senno Verhoef; Laura Van't Veer; Neil Aaronson
Journal:  Hered Cancer Clin Pract       Date:  2005-02-15       Impact factor: 2.857

9.  Protocol for the MoleMate UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379].

Authors:  Fiona M Walter; Helen C Morris; Elka Humphrys; Per N Hall; Ann Louise Kinmonth; A Toby Prevost; Edward Cf Wilson; Nigel Burrows; Paul Norris; Margaret Johnson; Jon Emery
Journal:  BMC Fam Pract       Date:  2010-05-11       Impact factor: 2.497

10.  Predictive value of breast cancer cognitions and attitudes toward genetic testing on women's interest in genetic testing for breast cancer risk.

Authors:  Frauke Reitz; Jürgen Barth; Jürgen Bengel
Journal:  Psychosoc Med       Date:  2004-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.